Slides from the mid-June ERA-EDTA 2019 Symposium "Vascular calcification in kidney disease: Epigenetics as a novel approach?" are now available on the PACE-CME website. You may need to create a free PACE-CME account to view/download. Great background on ALP, vascular calcification, CKD and cardiovascular risk, and a good summary of previously presented data related to apabetalone and BET inhibition in these areas. 

Epigenetic mechanisms targeting ALP: A pathway for prevention?

https://pace-cme.org/2019/07/03/slides-epigenetic-mechanisms-targeting-alp-a-pathway-for-prevention/

The role of ALP as predictor of cardiovascular events and vascular calcification in CKD

https://pace-cme.org/2019/07/03/slides-the-role-of-alp-as-predictor-of-cardiovascular-events-and-vascular-calcification-in-ckd/

Targeting residual cardiovascular risk & vascular calcification: The clinical perspective for BET inhibition

https://pace-cme.org/2019/07/03/slides-targeting-residual-cardiovascular-risk-vascular-calcification-the-clinical-perspective-for-bet-inhibition/